SecBot SecBot
← Back to Analyst Consensus
ONC Buy

BeOne Medicines Ltd.

Current Price —
Implied Upside —
Analysts 11

30-Day Momentum

▲ 0 upgrades  /  ▼ 0 downgrades  /  3 reiterations  from 3 firms

Rating Timeline

Date ▼FirmActionFrom → To RatingPrice TargetFirm Rating
Oct 8, 2026RBC CapitalmaintainOutperform → Outperform—55%
Oct 7, 2026Truist SecuritiesmaintainBuy → Buy—54%
Oct 1, 2026JP MorganmaintainOverweight → Overweight—55%
Sep 10, 2026BarclaysmaintainOverweight → Overweight—53%
Aug 6, 2026TD CowenmaintainBuy → Buy—54%
Aug 6, 2026RBC CapitalmaintainOutperform → Outperform—55%
Aug 6, 2026Truist SecuritiesmaintainBuy → Buy—54%
Aug 6, 2026GuggenheimmaintainBuy → Buy—52%
Aug 6, 2026BarclaysmaintainOverweight → Overweight—53%
Aug 6, 2026CitizensmaintainMarket Outperform → Market Outperform—47%
Jul 23, 2026JP MorganmaintainOverweight → Overweight—55%
Jul 14, 2026BarclaysmaintainOverweight → Overweight—53%
Jul 13, 2026JefferiesupgradeHold → Buy—52%
Jul 7, 2026RBC CapitalmaintainOutperform → Outperform—55%
Jul 7, 2026Truist SecuritiesmaintainBuy → Buy—54%
Jul 1, 2026CitizensreiterateMarket Outperform → Market Outperform—47%
Jun 2, 2026RBC CapitalmaintainOutperform → Outperform—55%
May 15, 2026Leerink PartnersmaintainOutperform → Outperform—51%
May 7, 2026RBC CapitalmaintainOutperform → Outperform—55%
May 7, 2026BarclaysmaintainOverweight → Overweight—53%
May 7, 2026GuggenheimmaintainBuy → Buy—52%
May 7, 2026Truist SecuritiesreiterateBuy → Buy—54%
May 4, 2026Wells Fargoinitiate— → Overweight—54%
Mar 27, 2026Wolfe Researchinitiate— → Outperform—54%
Mar 16, 2026JefferiesdowngradeBuy → Hold—52%
Feb 27, 2026RBC CapitalmaintainOutperform → Outperform$42555%
Feb 27, 2026Truist SecuritiesmaintainBuy → Buy$41254%
Feb 27, 2026GuggenheimmaintainBuy → Buy$41052%
Feb 27, 2026BarclaysmaintainOverweight → Overweight$40553%
Feb 4, 2026BarclaysmaintainOverweight → Overweight$39453%
Nov 24, 2025Truist Securitiesinitiate— → Buy$40054%
Nov 18, 2025RBC CapitalmaintainOutperform → Outperform$40855%
Nov 10, 2025CitigroupmaintainBuy → Buy$40554%
Nov 7, 2025RBC CapitalmaintainOutperform → Outperform$39555%
Nov 7, 2025CitizensmaintainMarket Outperform → Market Outperform$39647%
Oct 20, 2025Morgan StanleymaintainOverweight → Overweight$38354%
Oct 8, 2025JP MorganmaintainOverweight → Overweight$38555%
Sep 18, 2025Barclaysinitiate— → Overweight$38553%
Aug 7, 2025RBC CapitalmaintainOutperform → Outperform$36455%
Aug 7, 2025GuggenheimmaintainBuy → Buy$36552%
Jul 17, 2025JP MorganmaintainOverweight → Overweight$34555%
Jul 16, 2025RBC CapitalmaintainOutperform → Outperform$34955%
Jun 27, 2025Morgan StanleymaintainOverweight → Overweight$33054%
Jun 27, 2025JP MorganmaintainOverweight → Overweight$32155%
Jun 27, 2025RBC CapitalreiterateOutperform → Outperform$31155%
May 8, 2025RBC CapitalmaintainOutperform → Outperform$31155%
May 8, 2025GuggenheimmaintainBuy → Buy$35052%
Apr 28, 2025RBC CapitalreiterateOutperform → Outperform$31255%
Apr 24, 2025TD SecuritiesreiterateBuy → Buy$33453%
Apr 21, 2025JP MorganmaintainOverweight → Overweight$31755%

Price Target Trend

Jul 27, 2026 Oct 26, 2026

EPS Estimates

+1q —
0q —
0y —
+1y —

Cross-Platform Signals

No cross-platform signals in the last 90 days

Fresh Analyst Detail

Price targets, earnings estimates, and firm actions for this ticker — updated within the last 24 hours.

Subscribe for Full Access